TGA Approval

EBGLYSS lebrikizumab 250 mg/2 mL solution for injection autoinjector (pre-filled pen) (406290)

ARTG ID

406290

ARTG Name

EBGLYSS lebrikizumab 250 mg/2 mL solution for injection autoinjector (pre-filled pen)

Sponsor

Eli Lilly Australia Pty Ltd

ARTG Date

May 29, 2024

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

ELI LILLY AUSTRALIA PTY LTD

https://medical-cdn.nocode.com/drug_tga/d692e1109071f9a2b47f03f5b8166a56.pdf

https://medical-cdn.nocode.com/drug_tga/c89dec9fa71ee61876b9dfe47068f588.pdf

Ingredient Name

lebrikizumab

Empowering clinical research with data-driven insights and AI-powered tools.

EBGLYSS lebrikizumab 250 mg/2 mL solution for injection autoinjector (pre-filled pen) (406290) - TGA 批准文号 | MedPath